Earnings call transcript: Grupo Multilaser Q1 2026 sees robust growth

Grupo Multilaser delivered a strong Q1 2026, with revenue up 14.3% year over year to BRL 872 million, gross margin expanding to 30.4% from 23.7%, and EBITDA surging to BRL 96.5 million, the highest quarterly level since 2022. Net income rose 91% to BRL 123 million, aided by operational improvements and a BRL 35 million FX benefit, while the stock gained 2.48% after hours. Management kept guidance steady and highlighted ongoing supply-chain pressure from component shortages, but said price pass-through and portfolio optimization should support margins.

Analysis

This is less a clean demand story than a margin-reset story. The company is proving it can reprice through industry-wide component inflation, but the bigger second-order effect is that smaller, lower-value import-heavy competitors will likely be forced into either worse gross margins or slower inventory turns as the cost base resets upward. That creates a near-term relative winner set in distributors with local manufacturing, procurement access, and working-capital discipline; the losers are the pure traders and brands that depend on price elasticity to move volume.

The most important catalyst is not the current quarter, but the next 1-2 quarters when higher-cost inventory fully lands and the “advance-buy” tailwind rolls off. If pass-through holds, earnings can stay resilient; if not, the market is likely underestimating how quickly profitability can mean-revert because the business is operating with thin absolute revenue growth in some consumer lines. The company’s cash generation reduces balance-sheet risk materially, but it also raises the probability of capital returns becoming part of the equity case, which can support the stock even if top-line momentum cools.

The contrarian view is that consensus may be overweighting the headline margin expansion and underweighting how much was timing-driven. The real test is whether the operating margin is structurally higher once the one-off inventory and FX effects fade, especially with trade-policy noise still creating competitive pressure from informal or lightly taxed channels. If those pressures intensify, the stock could re-rate from a ‘turnaround’ multiple to a more normal industrial multiple quickly, making this more of a tactical long than a durable compounder unless management shows two more quarters of margin stability.

Key Decisions for Investors

• Long MLAS3 into 1H26 on pullbacks, targeting a 15-20% upside if margin holds above 28% and cash return policy becomes more explicit; use a 10-12% stop if Q2 commentary shows pass-through slipping.
• Pair trade: long MLAS3 / short a Brazil consumer-electronics or import-reliant retailer proxy over the next 1-2 quarters, betting on better pricing power and balance-sheet optionality at the local manufacturer.
• If liquid Brazilian single-name options are available, buy 3-6 month out-of-the-money calls on MLAS3 as a low-premium way to express continued de-rating reversal; risk/reward improves if the stock re-tests the 52-week high.
• Trim or avoid long exposure if management stops referencing dividend cadence by the next update; the cash story matters because it is the main defense against a post-earnings multiple giveback.
• Watch for a tactical short if component inflation persists but revenue decelerates for two consecutive quarters; that would be the signal that Q1 was timing-driven and margins are not sustainably reset higher.